Serotonin blood level study, anxiety-depressive states indicators and patients life quality after laparoscopic treatment of gastroesophageal reflux disease

Authors

DOI:

https://doi.org/10.14739/2310-1237.2024.1.288400

Keywords:

gastroesophageal reflux disease, anxiety, depression, quality of life, serotonin

Abstract

Nowadays effective treatment of gastroesophageal reflux disease (GERD) remains a difficult and still unsolved problem. The use of various antisecretory drugs in combination with surgical treatment does not allow to achieve a long lasting improvement of the quality of life and reliable prevention of complications. In this regard, special attention is paid to study humoral factors influencing the pathogenesis of GERD, data on which will improve the results of therapeutic and surgical treatment. It is promising to study the dynamics of serotonin after laparoscopic treatment of various types of GERD, especially in combination with dyspepsia, anxiety or depressive disorders, as well as the possibility of using drugs that affect the metabolism of this hormone to correct the above mentioned disorders and achieve long lasting recovery after laparoscopic fundoplication.

The aim of the work was to study the dynamics of serotonin in the blood during laparoscopic total fundoplication and analyze the correlation of this hormone with the psychological well-being of patients before and after surgical treatment of GERD.

Materials and methods. Laparoscopic fundoplication by Short Floppy Nissen modification was performed in 35 patients with GERD. There were 26 (74.3 %) women, 9 (25.7 %) men. Age – 55.3 ± 11.3. The comparison group consisted of 20 healthy volunteers (women – 14 (70.0 %); men – 6 (30.0 %), average age – 56.7 ± 10.6), who did not undergo surgery. The groups were comparable by gender and age. The studies were carried out in venous blood plasma, samples of which were maintained using standard methods and stored in a low-temperature freezer at a temperature of -80 °C. Tests for serotonin (Serotonin ELISA, RE59121, IBL) were studied on the immunoenzyme complex ImmunoChem-2100 (USA) of the Department of Clinical Laboratory Diagnostics in the Zaporizhzhia State Medical and Pharmaceutical University. The concentration of the last indicators was expressed in ng/ml. The presence of concomitant anxiety, depression and level of psychological well-being was assessed using the GAD-7, PHQ-9 and SF-36 questionnaires. Statistical assessment of the research results was carried out using the Statistica for Windows 13 software package (StatSoft Inc., No. JPZ804I382130ARCN10-J). Differences were considered statistically significant at p < 0.05.

Results. The serotonin level in the blood of practically healthy people was 5.8 ± 1.5 ng/ml. In the main group serotonin values before surgical treatment were 3.1 ± 1.3 ng/ml. After surgical treatment the serotonin level increased to 5.4 ± 1.8 ng/ml and was not statistically different from the level of practically healthy patients. The dynamics of serotonin levels correspond to the dynamics of the patients number with signs of anxiety and depression before and after surgery in the main group, as well as the improvement in the psychological state of patients after surgery compared to preoperative data on the scales of the “psychological component” of SF-36 health questionnaire: Vitality (VT), Social Functioning (SF), Role-Emotional (RE), Mental Health (MH).

Conclusions. Laparoscopic crurorrhaphy and fundoplication in the Short Floppy Nissen modification through the mechanism of serotonin helps to improve the psychological state of patients with GERD in the postoperative period, eliminate anxiety and depression, improve quality of life and achieve a lasting antireflux effect. The obtained dynamics of serotonin levels confirms its participation in the formation of behavioral reactions in GERD, helping to improve the results of surgical treatment.

Author Biography

Ye. I. Haidarzhi, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD, Associate Professor of the Department of Hospital Surgery

References

Schoppmann SF, Riegler M, editors. Multidisciplinary Management of Gastroesophageal Reflux Disease. Cham: Springer International Publishing; 2021. https://doi.org/10.1007/978-3-030-53751-7

Horgan S, Fuchs KH, editors. Management of Gastroesophageal Reflux Disease. Cham: Springer International Publishing; 2020. https://doi.org/10.1007/978-3-030-48009-7

Elchynski AL, Cicali EJ, Ferrer Del Busto MC, Hamilton A, Chang KL, Schmidt SO, et al. Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease. Pharmacogenomics J. 2021;21(6):657-63. doi: https://doi.org/10.1038/s41397-021-00244-6

Holcomb CN, Switzer NJ, Jalilvand A, Belle P, McNally M, Perry K. Impact of psychiatric disorders on patient satisfaction after Nissen Fundoplication. Surg Endosc. 2020;34(4):1829-34. doi: https://doi.org/10.1007/s00464-019-06949-x

Broers C, Geeraerts A, Boecxstaens V, Van Houtte B, Geysen H, Peersman N, et al. The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health. Neurogastroenterol Motil. 2021;33(3):e14057. doi: https://doi.org/10.1111/nmo.14057

Manolakis AC, Broers C, Geysen H, Goelen N, Van Houtte B, Rommel N, et al. Effect of citalopram on esophageal motility in healthy subjects-Implications for reflux episodes, dysphagia, and globus. Neurogastroenterol Motil. 2019;31(8):e13632. doi: https://doi.org/10.1111/nmo.13632

Serotonin ELISA (RE59121). Version 2014-11 (01). BL International GmbH; 2014 [cited 2024 Feb 1]. Available from: https://ibl-international.com/media/mageworx/downloads/attachment/file/r/e/re59121_ifu_eu_en_serotonin_elisa_2014-11-_01__sym9.pdf

Torfs SC, Maes AA, Delesalle CJ, Deprez P, Croubels SM. Comparative analysis of serotonin in equine plasma with liquid chromatography--tandem mass spectrometry and enzyme-linked immunosorbent assay. J Vet Diagn Invest. 2012;24(6):1035-42. doi: https://doi.org/10.1177/1040638712457928

Kluge H, Bolle M, Reuter R, Werner S, Zahlten W, Prudlo J. Serotonin in platelets: comparative analyses using new enzyme immunoassay and HPLC test kits and the traditional fluorimetric procedure. Lab J Lab Med. 1999;23(6):360-4. doi: https://doi.org/10.1515/labm.1999.23.6.360

Allan VJ. Basic immunofluorescence. In: Protein localization by fluorescence microscopy: A Practical Approach. Oxford University Press; 2023. p. 1-26. https://doi.org/10.1093/oso/9780199637416.003.0001

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. doi: https://doi.org/10.1001/archinte.166.10.1092

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13. doi: https://doi.org/10.1046/j.1525-1497.2001.016009606.x

Ware JE, Kosinski MA, Keller SD. SF-36 physical and mental health summary scales: A User’s Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.

Bayer H, Müller T, Myrtek D, Sorichter S, Ziegenhagen M, Norgauer J, et al. Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol. 2007;36(1):85-93. doi: https://doi.org/10.1165/rcmb.2006-0151OC

Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397-414. doi: https://doi.org/10.1053/j.gastro.2006.11.002

Oparin AA, Balaklytska IO, Morozova OG, Oparin AG, Khomenko LO. Mechanisms of insomnia formation with gastroesophageal reflux disease, taking into account the psychosomatic status in young people. Wiad Lek. 2020;73(7):1365-9.

Cheung CK, Lee YY, Chan Y, Cheong PK, Law WT, Lee SF, et al. Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2013;11(9):1125-9. doi: https://doi.org/10.1016/j.cgh.2013.03.026

Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol. 2005;39(5 Suppl 3):S184-93. doi: https://doi.org/10.1097/01.mcg.0000156403.37240.30

Fadeenko GD, Gridnev AE. Gastroezofagealnaia refliuksnaia bolezn: pishchevodnye i vnepishchevodnye proiavleniia i komorbidnost [Gastroesophageal reflux disease: esophageal, extraesophageal manifestations and comorbidity]. Kyiv: Biblioteka “Zdorov’e Ukrainy”; 2014. Russian.

Fuchs KH, Musial F, Ulbricht F, Breithaupt W, Reinisch A, Babic B, et al. Foregut symptoms, somatoform tendencies, and the selection of patients for antireflux surgery. Dis Esophagus. 2017;30(7):1-10. doi: https://doi.org/10.1093/dote/dox022

Downloads

Published

2024-04-22

How to Cite

1.
Haidarzhi YI. Serotonin blood level study, anxiety-depressive states indicators and patients life quality after laparoscopic treatment of gastroesophageal reflux disease. Pathologia [Internet]. 2024Apr.22 [cited 2024Jul.18];21(1):34-40. Available from: http://pat.zsmu.edu.ua/article/view/288400

Issue

Section

Original research